Global Spinal Muscular Atrophy Market Size, Status and Forecast 2025

March 2018 | 90 pages | ID: G6A530CBA42EN
QYResearch

Abstracts

This report studies the global Spinal Muscular Atrophy market, analyzes and researches the Spinal Muscular Atrophy development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like

• Lonis Pharmaceuticals
• F. Hoffmann-La Roche
• AveXis
• Novartis
• Cytokinetics
• Ionis Pharmaceuticals

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, the product can be split into

• Early Stage Candidates
• Late Stage Candidates

Market segment by Application, Spinal Muscular Atrophy can be split into

• Hospital
• Clinic
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Spinal Muscular Atrophy Market Size, Status and Forecast 2025

1 INDUSTRY OVERVIEW OF SPINAL MUSCULAR ATROPHY

1.1 Spinal Muscular Atrophy Market Overview
  1.1.1 Spinal Muscular Atrophy Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Spinal Muscular Atrophy Market Size and Analysis by Regions (2013-2018)
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Spinal Muscular Atrophy Market by Type
  1.3.1 Early Stage Candidates
  1.3.2 Late Stage Candidates
1.4 Spinal Muscular Atrophy Market by End Users/Application
  1.4.1 Hospital
  1.4.2 Clinic
  1.4.3 Others

2 GLOBAL SPINAL MUSCULAR ATROPHY COMPETITION ANALYSIS BY PLAYERS

2.1 Spinal Muscular Atrophy Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 Lonis Pharmaceuticals
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Spinal Muscular Atrophy Revenue (Million USD) (2013-2018)
  3.1.5 Recent Developments
3.2 F. Hoffmann-La Roche
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Spinal Muscular Atrophy Revenue (Million USD) (2013-2018)
  3.2.5 Recent Developments
3.3 AveXis
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Spinal Muscular Atrophy Revenue (Million USD) (2013-2018)
  3.3.5 Recent Developments
3.4 Novartis
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Spinal Muscular Atrophy Revenue (Million USD) (2013-2018)
  3.4.5 Recent Developments
3.5 Cytokinetics
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Spinal Muscular Atrophy Revenue (Million USD) (2013-2018)
  3.5.5 Recent Developments
3.6 Ionis Pharmaceuticals
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Spinal Muscular Atrophy Revenue (Million USD) (2013-2018)
  3.6.5 Recent Developments

4 GLOBAL SPINAL MUSCULAR ATROPHY MARKET SIZE BY TYPE AND APPLICATION (2013-2018)

4.1 Global Spinal Muscular Atrophy Market Size by Type (2013-2018)
4.2 Global Spinal Muscular Atrophy Market Size by Application (2013-2018)
4.3 Potential Application of Spinal Muscular Atrophy in Future
4.4 Top Consumer/End Users of Spinal Muscular Atrophy

5 UNITED STATES SPINAL MUSCULAR ATROPHY DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Spinal Muscular Atrophy Market Size (2013-2018)
5.2 United States Spinal Muscular Atrophy Market Size and Market Share by Players (2013-2018)
5.3 United States Spinal Muscular Atrophy Market Size by Application (2013-2018)

6 EU SPINAL MUSCULAR ATROPHY DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Spinal Muscular Atrophy Market Size (2013-2018)
6.2 EU Spinal Muscular Atrophy Market Size and Market Share by Players (2013-2018)
6.3 EU Spinal Muscular Atrophy Market Size by Application (2013-2018)

7 JAPAN SPINAL MUSCULAR ATROPHY DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Spinal Muscular Atrophy Market Size (2013-2018)
7.2 Japan Spinal Muscular Atrophy Market Size and Market Share by Players (2013-2018)
7.3 Japan Spinal Muscular Atrophy Market Size by Application (2013-2018)

8 CHINA SPINAL MUSCULAR ATROPHY DEVELOPMENT STATUS AND OUTLOOK

8.1 China Spinal Muscular Atrophy Market Size (2013-2018)
8.2 China Spinal Muscular Atrophy Market Size and Market Share by Players (2013-2018)
8.3 China Spinal Muscular Atrophy Market Size by Application (2013-2018)

9 INDIA SPINAL MUSCULAR ATROPHY DEVELOPMENT STATUS AND OUTLOOK

9.1 India Spinal Muscular Atrophy Market Size (2013-2018)
9.2 India Spinal Muscular Atrophy Market Size and Market Share by Players (2013-2018)
9.3 India Spinal Muscular Atrophy Market Size by Application (2013-2018)

10 SOUTHEAST ASIA SPINAL MUSCULAR ATROPHY DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Spinal Muscular Atrophy Market Size (2013-2018)
10.2 Southeast Asia Spinal Muscular Atrophy Market Size and Market Share by Players (2013-2018)
10.3 Southeast Asia Spinal Muscular Atrophy Market Size by Application (2013-2018)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2018-2025)

11.1 Global Spinal Muscular Atrophy Market Size (Value) by Regions (2018-2025)
  11.1.1 United States Spinal Muscular Atrophy Revenue and Growth Rate (2018-2025)
  11.1.2 EU Spinal Muscular Atrophy Revenue and Growth Rate (2018-2025)
  11.1.3 Japan Spinal Muscular Atrophy Revenue and Growth Rate (2018-2025)
  11.1.4 China Spinal Muscular Atrophy Revenue and Growth Rate (2018-2025)
  11.1.5 India Spinal Muscular Atrophy Revenue and Growth Rate (2018-2025)
  11.1.6 Southeast Asia Spinal Muscular Atrophy Revenue and Growth Rate (2018-2025)
11.2 Global Spinal Muscular Atrophy Market Size (Value) by Type (2018-2025)
11.3 Global Spinal Muscular Atrophy Market Size by Application (2018-2025)

12 SPINAL MUSCULAR ATROPHY MARKET DYNAMICS

12.1 Spinal Muscular Atrophy Market Opportunities
12.2 Spinal Muscular Atrophy Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Spinal Muscular Atrophy Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Spinal Muscular Atrophy Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global Spinal Muscular Atrophy Market Size (Million USD) Status and Outlook (2013-2018)
Table Global Spinal Muscular Atrophy Revenue (Million USD) Comparison by Regions (2013-2018)
Figure Global Spinal Muscular Atrophy Market Share by Regions (2013-2018)
Figure United States Spinal Muscular Atrophy Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure EU Spinal Muscular Atrophy Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Japan Spinal Muscular Atrophy Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure China Spinal Muscular Atrophy Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure India Spinal Muscular Atrophy Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Southeast Asia Spinal Muscular Atrophy Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table Global Spinal Muscular Atrophy Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
Figure Global Spinal Muscular Atrophy Revenue Market Share by Type in 2017
Figure Early Stage Candidates Market Size (Million USD) and Growth Rate (2013-2018)
Figure Late Stage Candidates Market Size (Million USD) and Growth Rate (2013-2018)
Figure Global Spinal Muscular Atrophy Market Share by Application in 2017
Figure Spinal Muscular Atrophy Market Size (Million USD) and Growth Rate in Hospital (2013-2018)
Figure Spinal Muscular Atrophy Market Size (Million USD) and Growth Rate in Clinic (2013-2018)
Figure Spinal Muscular Atrophy Market Size (Million USD) and Growth Rate in Others (2013-2018)
Table Spinal Muscular Atrophy Market Size (Million USD) by Players (2013-2018)
Figure Spinal Muscular Atrophy Market Size Share by Players in 2013
Figure Spinal Muscular Atrophy Market Size Share by Players in 2017
Table Lonis Pharmaceuticals Basic Information List
Table Spinal Muscular Atrophy Business Revenue (Million USD) of Lonis Pharmaceuticals (2013-2018)
Figure Lonis Pharmaceuticals Spinal Muscular Atrophy Business Revenue Market Share (2013-2018)
Table F. Hoffmann-La Roche Basic Information List
Table Spinal Muscular Atrophy Business Revenue (Million USD) of F. Hoffmann-La Roche (2013-2018)
Figure F. Hoffmann-La Roche Spinal Muscular Atrophy Business Revenue Market Share (2013-2018)
Table AveXis Basic Information List
Table Spinal Muscular Atrophy Business Revenue (Million USD) of AveXis (2013-2018)
Figure AveXis Spinal Muscular Atrophy Business Revenue Market Share (2013-2018)
Table Novartis Basic Information List
Table Spinal Muscular Atrophy Business Revenue (Million USD) of Novartis (2013-2018)
Figure Novartis Spinal Muscular Atrophy Business Revenue Market Share (2013-2018)
Table Cytokinetics Basic Information List
Table Spinal Muscular Atrophy Business Revenue (Million USD) of Cytokinetics (2013-2018)
Figure Cytokinetics Spinal Muscular Atrophy Business Revenue Market Share (2013-2018)
Table Ionis Pharmaceuticals Basic Information List
Table Spinal Muscular Atrophy Business Revenue (Million USD) of Ionis Pharmaceuticals (2013-2018)
Figure Ionis Pharmaceuticals Spinal Muscular Atrophy Business Revenue Market Share (2013-2018)
Table Global Spinal Muscular Atrophy Market Size (Million USD) by Product (2013-2018)
Figure Global Spinal Muscular Atrophy Revenue Market Share (%) by Product (2013-2018)
Figure Global Spinal Muscular Atrophy Market Share by Product in 2017
Table Global Spinal Muscular Atrophy Market Size by Application (2013-2018)
Figure Global Spinal Muscular Atrophy Revenue Market Share (%) by Application in 2017
Table Top Consumer/End Users of Spinal Muscular Atrophy
Figure United States Spinal Muscular Atrophy Market Size (Million USD) and Growth Rate (2013-2018)
Table United States Spinal Muscular Atrophy Market Size (Million USD) by Players (2013-2018)
Figure United States Spinal Muscular Atrophy Market Size Share by Players in 2013
Figure United States Spinal Muscular Atrophy Market Size Share by Players in 2017
Table United States Spinal Muscular Atrophy Market Size by Application (2013-2018)
Figure United States Spinal Muscular Atrophy Revenue Market Share (%) by Application (2013-2018)
Figure United States Spinal Muscular Atrophy Market Size Share by Application in 2017
Figure EU Spinal Muscular Atrophy Market Size (Million USD) and Growth Rate (2013-2018)
Table EU Spinal Muscular Atrophy Market Size (Million USD) by Players (2013-2018)
Figure EU Spinal Muscular Atrophy Market Size Share by Players in 2013
Figure EU Spinal Muscular Atrophy Market Size Share by Players in 2017
Table EU Spinal Muscular Atrophy Market Size by Application (2013-2018)
Figure EU Spinal Muscular Atrophy Revenue Market Share (%) by Application (2013-2018)
Figure EU Spinal Muscular Atrophy Market Size Share by Application in 2017
Figure Japan Spinal Muscular Atrophy Market Size (Million USD) and Growth Rate (2013-2018)
Table Japan Spinal Muscular Atrophy Market Size (Million USD) by Players (2013-2018)
Figure Japan Spinal Muscular Atrophy Market Size Share by Players in 2013
Figure Japan Spinal Muscular Atrophy Market Size Share by Players in 2017
Table Japan Spinal Muscular Atrophy Market Size by Application (2013-2018)
Figure Japan Spinal Muscular Atrophy Revenue Market Share (%) by Application (2013-2018)
Figure Japan Spinal Muscular Atrophy Market Size Share by Application in 2017
Figure China Spinal Muscular Atrophy Market Size (Million USD) and Growth Rate (2013-2018)
Table China Spinal Muscular Atrophy Market Size (Million USD) by Players (2013-2018)
Figure China Spinal Muscular Atrophy Market Size Share by Players in 2013
Figure China Spinal Muscular Atrophy Market Size Share by Players in 2017
Table China Spinal Muscular Atrophy Market Size by Application (2013-2018)
Figure China Spinal Muscular Atrophy Revenue Market Share (%) by Application (2013-2018)
Figure China Spinal Muscular Atrophy Market Size Share by Application in 2017
Figure India Spinal Muscular Atrophy Market Size (Million USD) and Growth Rate (2013-2018)
Table India Spinal Muscular Atrophy Market Size (Million USD) by Players (2013-2018)
Figure India Spinal Muscular Atrophy Market Size Share by Players in 2013
Figure India Spinal Muscular Atrophy Market Size Share by Players in 2017
Table India Spinal Muscular Atrophy Market Size by Application (2013-2018)
Figure India Spinal Muscular Atrophy Revenue Market Share (%) by Application (2013-2018)
Figure India Spinal Muscular Atrophy Market Size Share by Application in 2017
Figure Southeast Asia Spinal Muscular Atrophy Market Size (Million USD) and Growth Rate (2013-2018)
Table Southeast Asia Spinal Muscular Atrophy Market Size (Million USD) by Players (2013-2018)
Figure Southeast Asia Spinal Muscular Atrophy Market Size Share by Players in 2013
Figure Southeast Asia Spinal Muscular Atrophy Market Size Share by Players in 2017
Table Southeast Asia Spinal Muscular Atrophy Market Size by Application (2013-2018)
Figure Southeast Asia Spinal Muscular Atrophy Revenue Market Share (%) by Application (2013-2018)
Figure Southeast Asia Spinal Muscular Atrophy Market Size Share by Application in 2017
Figure Global Spinal Muscular Atrophy Market Size and Growth Rate (2018-2025)
Table Global Spinal Muscular Atrophy Market Size (Million USD) by Regions (2018-2025)
Figure Global Spinal Muscular Atrophy Market Size Share (2018-2025)
Figure Global Spinal Muscular Atrophy Market Size Share by Regions in 2025
Figure United States Spinal Muscular Atrophy Revenue (Million USD) and Growth Rate (2018-2025)
Figure EU Spinal Muscular Atrophy Revenue (Million USD) and Growth Rate (2018-2025)
Figure Japan Spinal Muscular Atrophy Revenue (Million USD) and Growth Rate (2018-2025)
Figure China Spinal Muscular Atrophy Revenue (Million USD) and Growth Rate (2018-2025)
Figure India Spinal Muscular Atrophy Revenue (Million USD) and Growth Rate (2018-2025)
Figure Southeast Asia Spinal Muscular Atrophy Revenue (Million USD) and Growth Rate (2018-2025)
Table Global Spinal Muscular Atrophy Market Size (Million USD) by Type (2018-2025)
Figure Global Spinal Muscular Atrophy Market Size Share by Type in 2018
Figure Global Spinal Muscular Atrophy Market Size Share by Type in 2025
Table Global Spinal Muscular Atrophy Market Size (Million USD) by Application (2018-2025)
Figure Global Spinal Muscular Atrophy Market Size (Million USD) by Application in 2018
Figure Global Spinal Muscular Atrophy Market Size (Million USD) by Application in 2025